MIT Technology Review: Trump’s antibody treatment was tested using cells originally derived from an abortion

MIT Technology Review: Trump’s antibody treatment was tested using cells originally derived from an abortion. “The emergency antibody that Trump received last week was developed with the use of a cell line originally derived from abortion tissue, according to Regeneron Pharmaceuticals, the company that developed the experimental drug. The Trump administration has taken an increasingly firm line against medical research using fetal tissue from abortions.”

Leave a Reply